Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Description CJC 1295 is a synthetic growth hormone-releasing hormone (GHRH) analog designed to increase growth hormone (GH) levels
In obesity, GIP receptor activation is believed to contribute to the weight loss and metabolic effects observed with triple-agonist agents
Large phase 3 trials, including cardiovascular-outcome studies, are ongoing and had not reported results as of mid-2026 (ClinicalTrials.gov NCT05882045
There are two groups of diseases whose causes are studied in yeast: diseases caused by human genes that have orthologs in S
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
